Table 1. RMSE per cancer type and drug in the CCLE dataset.
| Cancers | Drug Paclitaxel | AZD6244 | Nilotinib | PLX4720 | Sorafenib | Erlotinib | Lapatinib |
|---|---|---|---|---|---|---|---|
| Lung | 2.99 | 3.59 | 2.77 | 3.85 | 2.82 | 5.08 | 3.87 |
| Haematopoietic and lymphoid tissue | 2.98 | 2.68 | 2.42 | 3.33 | 3.05 | 4.88 | 3.89 |
| Bone | 3.96 | 3.01 | NA | 2.5 | 2.78 | 3.61 | 3.96 |
| Skin | 1.63 | 4.71 | 2.02 | 5.3 | 1.19 | 2.66 | 3.22 |
| Ovary | NA | 3.33 | 3.18 | 3.77 | NA | NA | NA |
| Central nervous system | 2.67 | 4.51 | 2.83 | 3.66 | 2.29 | 2.41 | 2.47 |
| Pancreas | NA | 2.08 | 4.34 | 3.85 | NA | NA | NA |
| Soft tissue | 0.64 | 3.01 | 2.88 | 2.88 | 3.77 | 3.99 | 3.59 |
| Breast | 2.23 | 3.87 | 3.17 | NA | 3.67 | 5.19 | 5.28 |
| Upper aerodigestive tract | 0.52 | 2.3 | 2.73 | NA | 1.86 | 2.17 | 1.49 |
| Kidney | 1.22 | NA | 2.88 | NA | NA | NA | NA |
| Thyroid | NA | 2.51 | 2.58 | 1.71 | NA | NA | NA |
NAs appear when not enough data were available.